Aetna Denied Your Allergy Treatment? How to Appeal

Aetna serves approximately 34 million members through employer-sponsored, ACA marketplace, and Medicare Advantage plans. Despite broad coverage, allergy testing and immunotherapy claims are frequently denied — typically on medical necessity grounds or because specific allergy protocols fall outside Aetna's internal clinical criteria. Aetna uses Clinical Policy Bulletin 0247 (allergy testing) and CPB 0545 (allergen immunotherapy), both available at aetna.com/cpb, to govern coverage determinations in this area. Relevant ICD-10 codes include J30.x (allergic rhinitis), J45.x (asthma), L20.x (atopic dermatitis), and T78.1xx (anaphylaxis). Most allergy treatment denials can be overturned when the right documentation and legal arguments are assembled.

Why Aetna Denies Allergy Claims

The most common reasons Aetna denies allergy claims cluster around a few well-established patterns.

• Not medically necessary — Aetna's utilization review team determines the testing or treatment does not meet CPB 0247 or CPB 0545 criteria. This is the most common denial and the most frequently overturned on appeal when proper documentation is submitted.
• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained — Allergy immunotherapy (allergy shots) and some diagnostic testing require prior authorization. If authorization was not obtained before treatment began, the claim is denied regardless of clinical appropriateness.
• Alternative treatment available — Aetna argues sublingual immunotherapy (SLIT) drops are an adequate alternative to subcutaneous immunotherapy (SCIT), or conversely denies SLIT as investigational. Aetna's CPBs classify FDA-approved SLIT tablets differently from compounded SLIT drops — confirm which product was used.
• Documentation insufficient — Allergy test results, specific allergens tested, and clinical justification for immunotherapy are not adequately documented in the submitted records.
• Experimental or investigational — Sublingual immunotherapy drops (SLIT drops, as distinct from FDA-approved SLIT tablets) are classified as investigational by Aetna even when widely used by board-certified allergists.
• Frequency or quantity limits exceeded — Claims for allergy injections exceeding CPB-defined frequency or quantity limits are denied administratively regardless of clinical need.

How to Appeal an Aetna Allergy Treatment Denial

Step 1: Identify the specific CPB and criteria cited in the denial

Download CPB 0247 (allergy testing) and/or CPB 0545 (immunotherapy) from aetna.com/cpb. Read the specific criteria Aetna claims were not met. Request the complete claims file under ERISA §1133 or ACA §2719 if these criteria are not identified in the denial letter. Note the CPB's last update date — if it predates current AAAAI or ACAAI practice parameters, cite the more current guidelines in the appeal.

Step 2: Document the allergy diagnosis and testing comprehensively

Gather: allergy skin testing or RAST (specific IgE) test results with clinically significant findings; spirometry results if allergic asthma (J45.x) is involved; documentation of allergic symptoms and their impact on quality of life and daily activities; and prior treatment history with documented inadequate response (antihistamines, nasal corticosteroids, pharmacological management).

Step 3: Obtain a letter of medical necessity from the treating allergist

The letter should: establish the allergy diagnosis with ICD-10 codes (J30.x, J45.x, L20.x, or T78.1xx as applicable); document the clinical rationale for the specific treatment requested; address Aetna's CPB criteria directly, citing the specific provision and explaining how the patient's case meets it; and cite AAAAI or ACAAI practice parameters supporting the treatment. The letter must be specific to Aetna's CPB — generic letters without CPB citations are often insufficient.

Step 4: Request peer-to-peer review

Your treating allergist can call Aetna's medical director at 1-888-MD-AETNA to discuss the case clinically. Peer-to-peer review is particularly effective for allergy immunotherapy denials where the clinical evidence of symptom burden and prior treatment failure is well-documented. Request this as soon as the denial is received, without waiting for the formal appeal deadline.

Step 5: Write and file the internal appeal letter

Address the CPB criteria point by point. Include the allergist's medical necessity letter, test results, and AAAAI or ACAAI guideline citations. Invoke ACA §2719 for appeal rights and ERISA §1133 for claims file access (employer plans). File at aetna.com/members or by certified mail within 180 days of the denial date. For urgent allergic conditions (severe allergic disease, anaphylaxis risk), invoke expedited 72-hour review under ACA §2719.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">external review if the internal appeal is denied

Request external review by an allergy/immunology-trained reviewer. Allergy immunotherapy denials that document clinical necessity per AAAAI/ACAAI guidelines are frequently overturned at the external review stage because external reviewers apply generally accepted clinical standards rather than Aetna's proprietary CPB criteria.

What to Include in Your Appeal

• Denial letter with specific CPB provision cited, plus Aetna CPB 0247 and/or CPB 0545 downloaded from aetna.com/cpb
• Allergy testing results (skin test or specific IgE RAST) with clinically significant findings, plus spirometry if allergic asthma (J45.x) is involved
• Treating allergist's letter of medical necessity with ICD-10 codes and AAAAI or ACAAI practice parameter citations for the specific treatment requested
• Prior treatment history documenting inadequate response to antihistamines, nasal corticosteroids, and other pharmacological management
• Peer-to-peer review request confirmation and prior authorization submission and response (if applicable)

Fight Back With ClaimBack

Aetna's allergy CPBs can be more restrictive than current AAAAI and ACAAI guidelines. When an allergist's documentation addresses CPB criteria directly and cites current practice parameters, these denials are highly reversible on appeal. ClaimBack generates a professional, Aetna-specific appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal